The properties of Gd 2O 3-assembled silica nanocomposite targeted nanoprobes and their application in MRI

Biomaterials

Volumn 33, Issue 27, 2012, Pages 6438-6446

  Shao, Yuanzhi ^a   Tian, Xiumei ^b,c   Hu, Wenyong ^a   Zhang, Yongyu ^b   Liu, Huan ^a   He, Haoqiang ^b   Shen, Yingying ^b,c   Xie, Fukang ^c   Li, Li ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atomistic and Melocular modeling; Biocompatibility and pharmacodynamics; Silica; Synthesis; Targeted nanoprobe

Indexed keywords

BIODISTRIBUTIONS; CONTRAST ENHANCEMENT; FIRST-PRINCIPLES CALCULATION; HEPATOBILIARY; HIGH POTENTIAL; IN-VIVO; MESOPOROUS SILICA; MR IMAGING; RELAXIVITY; SILICA NANOCOMPOSITES; TRANSPORT MECHANISM;

BIOCOMPATIBILITY; CALCULATIONS; GADOLINIUM; GADOLINIUM COMPOUNDS; MAGNETIC RESONANCE IMAGING; MESOPOROUS MATERIALS; MOLECULAR IMAGING; NANOPROBES; SILICA; SYNTHESIS (CHEMICAL);

NANOCOMPOSITES;

BIOMATERIAL; GADOLINIUM OXIDE; GADOLINIUM PENTETATE; NANOCOMPOSITE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTON; SILICON DIOXIDE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GADOLINIUM;

ANIMAL CELL; ARTICLE; BRAIN; BRAIN LEVEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXCRETION; HEART; HEPATOBILIARY SYSTEM; IN VIVO STUDY; KIDNEY; LIVER LEVEL; LUNG; MOLECULAR IMAGING; MOLECULAR MODEL; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SPLEEN; SYNTHESIS; VALIDATION STUDY; ADSORPTION; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL CYCLE; CELL LINE; CELL SURVIVAL; COMPUTER SIMULATION; DRUG EFFECT; ELECTRON; HUMAN; MALE; MATERIALS TESTING; METHODOLOGY; MOLECULAR PROBE; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ADSORPTION; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL SURVIVAL; COMPUTER SIMULATION; ELECTRONS; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MATERIALS TESTING; MICE; MICE, INBRED BALB C; MOLECULAR PROBES; NANOCOMPOSITES; SILICON DIOXIDE; TISSUE DISTRIBUTION;

EID: 84863562759     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.065     Document Type: Article

References (42)

1. Gao J., Gu H., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 2009, 42:1097-1107.
2. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
3. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
4. Rosenholm J.M., Peuhu E., Eriksson J.E., Sahlgren C., Lindén M. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. Nano Lett 2009, 9:3308-3311.
5. Vallet-Regí M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007, 46:7548-7558.
6. Barbe C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M., et al. Silica particles: a novel drug-delivery system. Adv Mater 2004, 16:1959-1966.
7. Kneuer C., Sameti M., Haltner E.G., Schiestel T., Schirra H., Schmidt H., et al. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int J Pharm 2000, 196:257-261.
8. Roy I., Ohulchanskyy T.Y., Bharali D.J., Pudavar H.E., Mistretta R.A., Kaur N., et al. Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. P Natl Acad Sci USA 2005, 102:279-284.
9. Yu H., Zhai Q.-Z. Mesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipine. Microporous Mesoporous Mater 2009, 123:298-305.
10. Sumer B., Gao J. Theranostic nanomedicine for cancer. Nanomedicine 2008, 3:137-140.
11. Selvi B.R., Jagadeesan D., Suma B.S., Nagashankar G., Arif M., Balasubramanyam K., et al. Intrinsically fluorescent carbon nanospheres as a nuclear targeting vector: delivery of membrane-impermeable molecule to modulate gene expression in vivo. Nano Lett 2008, 8:3182-3188.
12. Shan L. Gadolinium-incorporated mesoporous silica nanoparticles. Gadolinium-incorporated mesoporous silica nanoparticles. Mol Imaging Contrast Agent Database (MICAD) [database online].
13. van Schooneveld M.M., Vucic E., Koole R., Zhou Y., Stocks J., Cormode D.P., et al. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 2008, 8:2517-2525.
14. Zhu Z.-J., Carboni R., Quercio M.J., Yan B., Miranda O.R., Anderton D.L., et al. Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish. Small 2010, 6:2261-2265.
15. Kumar R., Roy I., Ohulchanskyy T.Y., Goswami L.N., Bonoiu A.C., Bergey E.J., et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2008, 2:449-456.
16. Oberdörster G., Oberdörster E., Oberdörster J. Concepts of nanoparticle dose metric and response metric. Environ Health Perspect 2007, 115:A290.
17. Fischer H.C., Chan W.C.W. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 2007, 18:565-571.
18. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007, 2:469-478.
19. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 2010, 62:362-374.
20. Mohammadi-Nejad A.-R., Hossein-Zadeh G.-A., Soltanian-Zadeh H. Quantitative evaluation of optimal imaging parameters for single-cell detection in MRI using simulation. Magn Reson Imaging 2010, 28:408-417.
21. Petri-Fink A., Hofmann H. Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies-a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Trans Nanobiosci 2007, 6:289-297.
22. Cho M., Cho W.-S., Choi M., Kim S.J., Han B.S., Kim S.H., et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009, 189:177-183.
23. He Q., Zhang Z., Gao Y., Shi J., Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 2009, 5:2722-2729.
24. Carrero-Sanchez J.C., Elías A.L., Mancilla R., Arrellín G., Terrones H., Laclette J.P., et al. Biocompatibility and toxicological studies of carbon nanotubes doped with nitrogen. Nano Lett 2006, 6:1609-1616.
25. Burns A.A., Vider J., Ow H., Herz E., Penate-Medina O., Baumgart M., et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 2009, 9:442-448.
26. Taylor K.M.L., Kim J.S., Rieter W.J., An H., Lin W., Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 2008, 130:2154-2155.
27. Shao Y.-Z., Liu L.-Z., Song S.-Q., Cao R.-H., Liu H., Cui C.-Y., et al. A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent. Contrast Media Mol Imaging 2011, 6:110-118.
28. Bhakta G., Sharma R.K., Gupta N., Cool S., Nurcombe V., Maitra A. Multifunctional silica nanoparticles with potentials of imaging and gene delivery. Nanomedicine 2011, 7:472-479.
29. Selvan S.T., Tan T.T.Y., Yi D.K., Jana N.R. Functional and multifunctional nanoparticles for bioimaging and biosensing. Langmuir 2010, 26:11631-11641.
30. 3 as a highly efficient magnetic resonance imaging contrast agent. Appl Phys Lett 2011, 98:093704.
31. Gordon S., Lawson L., Rabinowitz S., Crocker P.R., Morris L., Perry V.H. Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol 1992, 181:1-37.
32. Wink D.A., Hines H.B., Cheng R.Y.S., Switzer C.H., Flores-Santana W., Vitek M.P., et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 2011, 89:873-891.
33. Sancho D., Gómez M., Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005, 26:136-140.
34. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-258.
35. Hsu S.M., Raine L., Fanger H. The use of antividin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 1981, 75:816-821.
36. Cheon J., Lee J.-hyun Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 2008, 41:1630-1640.
37. Pulskamp K., Diabaté S., Krug H.F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007, 168:58-74.
38. Marque V., Kieffer P., Gayraud B., Lartaud-Idjouadiene I., Ramirez F., Atkinson J. Aortic wall mechanics and composition in a transgenic mouse model of marfan syndrome. Arterioscler Thromb Vasc Biol 2001, 21:1184-1189.
39. Weinmann H., Brasch R., Press W., Wesbey G. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 1984, 142:619-624.
40. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003, 125:7860-7865.
41. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J.A.M., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
42. Sonavane G., Tomoda K., Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surface B 2008, 66:274-280.